1. Celgene Corporation (17 from 549 patents)

2. Janssen Biotech, Inc. (13 from 410 patents)

3. Signal Pharmaceuticals, Inc. (8 from 169 patents)

4. Lifescan Corporation (4 from 298 patents)

5. Celgene Car LLC (4 from 44 patents)

6. Janssen Pharmaceutica Nv (3 from 2,077 patents)

7. The Cleveland Clinic Foundation (1 from 1,036 patents)

1. 12441985 - Methods for making insulin in vivo

2. 12343346 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same

3. 11890304 - Pancreatic endocrine cells and methods thereof

4. 11708562 - Differentiation of human embryonic stem cells

5. 11629153 - Forms and compositions of a MK2 inhibitor

6. 11369642 - Methods for lowering blood glucose

7. 11241439 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same

8. 10882867 - Forms and compositions of a MK2 inhibitor

9. 10704025 - Use of noggin, an ALK5 inhibitor and a protein kinase c activator to produce endocrine cells

10. 10596180 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same

11. 10513519 - Solid forms of (1S,4S)-4-(2-(((3S,4R)-3-fluorotetrahydro-2H-pyran-4-yl)amino)-8-((2,4,6-trichlorophenyl)amino)-9H-purin-9-yl)-1-methylcyclohexane-1-carboxamide and methods of their use

12. 10471104 - Lowering blood glucose

13. 10463672 - Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same

14. 10456424 - Pancreatic endocrine cells and methods thereof

15. 10202364 - Forms and compositions of an ERK inhibitor